Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset.
Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Ito Y, et al. Among authors: ishigure k. Ann Surg Oncol. 2020 Jan;27(1):268-275. doi: 10.1245/s10434-019-07781-2. Epub 2019 Sep 6. Ann Surg Oncol. 2020. PMID: 31493125
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801).
Nakayama G, Uehara K, Ishigure K, Yokoyama H, Ishiyama A, Eguchi T, Tsuboi K, Ohashi N, Fujii T, Sugimoto H, Koike M, Fujiwara M, Ando Y, Kodera Y. Nakayama G, et al. Among authors: ishigure k. Cancer Chemother Pharmacol. 2012 Oct;70(4):575-81. doi: 10.1007/s00280-012-1948-1. Epub 2012 Aug 12. Cancer Chemother Pharmacol. 2012. PMID: 22886005 Free PMC article. Clinical Trial.
Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial.
Misawa K, Fujiwara M, Ando M, Ito S, Mochizuki Y, Ito Y, Onishi E, Ishigure K, Morioka Y, Takase T, Watanabe T, Yamamura Y, Morita S, Kodera Y. Misawa K, et al. Among authors: ishigure k. Gastric Cancer. 2015 Apr;18(2):417-25. doi: 10.1007/s10120-014-0374-y. Epub 2014 May 7. Gastric Cancer. 2015. PMID: 24801197 Clinical Trial.
Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial.
Fujii T, Nakao A, Murotani K, Okamura Y, Ishigure K, Hatsuno T, Sakai M, Yamada S, Kanda M, Sugimoto H, Nomoto S, Takeda S, Morita S, Kodera Y. Fujii T, et al. Among authors: ishigure k. Ann Surg Oncol. 2015 Nov;22(12):3905-12. doi: 10.1245/s10434-015-4496-1. Epub 2015 Mar 17. Ann Surg Oncol. 2015. PMID: 25777090 Clinical Trial.
Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701).
Nakanishi K, Kobayashi D, Mochizuki Y, Ishigure K, Ito S, Kojima H, Ishiyama A, Fujitake S, Shikano T, Morita S, Kodera Y. Nakanishi K, et al. Among authors: ishigure k. Int J Clin Oncol. 2016 Jun;21(3):557-65. doi: 10.1007/s10147-015-0919-z. Epub 2015 Nov 7. Int J Clin Oncol. 2016. PMID: 26547424 Clinical Trial.
Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study.
Kamiya T, Uehara K, Nakayama G, Ishigure K, Kobayashi S, Hiramatsu K, Nakayama H, Yamashita K, Sakamoto E, Tojima Y, Kawai S, Kodera Y, Nagino M; Nagoya Surgical Oncology Group and the Chubu Clinical Oncology Group. Kamiya T, et al. Among authors: ishigure k. Eur J Surg Oncol. 2016 Jun;42(6):829-35. doi: 10.1016/j.ejso.2016.02.014. Epub 2016 Feb 27. Eur J Surg Oncol. 2016. PMID: 26968228 Clinical Trial.
The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
Kataoka M, Kanda M, Ishigure K, Matsuoka H, Sato Y, Takahashi T, Tanaka C, Deguchi T, Shibata Y, Sato M, Inagaki H, Matsui T, Kondo A, Takano N, Tanaka H, Sakamoto J, Oba K, Kondo K. Kataoka M, et al. Among authors: ishigure k. Ann Surg Oncol. 2017 Feb;24(2):546-553. doi: 10.1245/s10434-016-5557-9. Epub 2016 Sep 8. Ann Surg Oncol. 2017. PMID: 27638675 Clinical Trial.
80 results